Anirban Maitra, Laura and Isaac Perlmutter Professor of Pathology and Director of the Perlmutter Cancer Center at NYU Langone Health, shared on LinkedIn:
“A video tribute to Dr. Peter Martin, the Lymphoma Research Foundation 2026 Distinguished Leadership Award honoree.
John Leonard, Lisa Giulino Roth, MD, NYU Langone Health, NYU Grossman School of Medicine
Congratulations Peter!!”
About Peter Martin’s Distinguished Leadership Award
Peter Martin, a hematologist-oncologist at NYU Langone Health, was selected to receive the 2026 Distinguished Leadership Award from the Lymphoma Research Foundation in recognition of his contributions to lymphoma research, clinical care and the development of new treatment approaches.
The recognition was part of the Foundation’s 2026 Annual Gala, held on November 13 at the Ziegfeld Ballroom in New York City, bringing together leaders in lymphoma research, patient advocacy and philanthropy.
Martin has played an important role in advancing research on mantle cell lymphoma (MCL), including his leadership as chair of the Foundation’s Mantle Cell Lymphoma Consortium. The consortium supports scientific collaboration and progress toward improved treatment strategies for patients with this disease.
The annual gala also recognized AbbVie with the Corporate Leadership Award and the Werner Family with the Legacy Award, highlighting contributions to lymphoma research, patient support and philanthropy.
The event supports the Foundation’s mission to advance lymphoma research and improve outcomes for patients and families affected by the disease.
You can also read:
